BRD2 anticorps (intact)

N° du produit ABIN235189

Détail du produit anti-BRD2 anticorps

Antigène: BRD2 (Bromodomain Containing 2 (BRD2))

Épitope: intact

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp BRD2 est non-conjugé

Application: ELISA, Radioimmunoassay (RIA), Protein Assay (PrA)

Specificité: Recognizes the c1 epitope, a conformational epitope which is only detectable when the alpha and beta subunits of FSH are associated (intact FSH). No cross-reaction is detected in RIA with human FSH beta or any other human glycoprotein hormone or subunit thereof. Two-site sandwich ELISA revealed recognition of a conformational epitope on intact human FSH which is located near the alpha 1, alpha 2 and alpha 4 epitopes.

Attributs du produit: MAb to Human FSH (intact), Monoclonal antibody to Human Follicle Stimulating Hormone (FSH) intact, cl epitope, Tissue culture Hybridization of X63-Ag8.653 myeloma cells.

Purification: Protein A Chromatography. Tissue culture

Pureté: > 95 % pure (SDS PAGE)

Immunogène: Human FSH

Clone: INN-hFSH-117

Isotype: IgG1

Information d'application

Indications d'application: Suitable for use in ELISA and Radioimmunoassay.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Hanks balanced salt solution, 0.09 % Sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid multiple freeze/thaw cycles.
Centrifuge product if not completely clear after standing at room temperature.
Prepare working dilution only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Short-term (up to 1 month) store at 2-8 °C. Long term, aliquot and store at -28 °C.

Date de péremption: 1 month

Détails sur BRD2

Antigène: BRD2 (Bromodomain Containing 2 (BRD2))

Autre désignation: Follie Stimulating Hormone (FSH) (BRD2 Produits)

Synonymes: anticorps D6S113E, anticorps FSH, anticorps FSRG1, anticorps NAT, anticorps RING3, anticorps RNF3, anticorps AW228947, anticorps D17H6S113E, anticorps Frg-1, anticorps Fsrg-1, anticorps Fsrg1, anticorps Nat, anticorps Ring3, anticorps Rnf3, anticorps mKIAA4005, anticorps brd2-a, anticorps fsh, anticorps fsrg1, anticorps nat, anticorps ring3, anticorps rnf3, anticorps brd2, anticorps fe47f02, anticorps fi85h05, anticorps wu:fe47f02, anticorps wu:fi85h05, anticorps Ring3 protein, anticorps bromodomain containing 2, anticorps bromodomain containing 2 S homeolog, anticorps bromodomain containing 2a, anticorps CHLREDRAFT_190116, anticorps CHLREDRAFT_150233, anticorps CHLREDRAFT_182576, anticorps CHLREDRAFT_188250, anticorps BRD2, anticorps Brd2, anticorps brd2.S, anticorps brd2a

Pathways: Chromatin Binding, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2